Gliomatosis Cerebri

KEY FACTS

TERMINOLOGY

• Diffusely infiltrating, frequently bilateral glial tumor

involving at least 3 lobes

• Infiltrative extent of tumor is out of proportion to histologic

and clinical features

IMAGING

• T2 hyperintense infiltrating mass with enlargement of

involved structures

○ Typical cerebral hemispheres (75%)

○ Brain architecture enlarged, distorted, but preserved

• Typically no or minimal enhancement

• Enhancement may indicate malignant progression or focus

of malignant glioma

• MRS: Increased choline, decreased NAA

TOP DIFFERENTIAL DIAGNOSES

• Arteriolosclerosis

• Vasculitis

• Anaplastic astrocytoma

• Viral encephalitis

• Demyelination

PATHOLOGY

• Usually WHO grade III; range grade II-IV

• Shares many features of diffusely infiltrating astrocytoma

• Rarely, oligodendroglioma is predominant cell type

• Diagnosis typically made on basis of histology and imaging

CLINICAL ISSUES

• Presenting symptoms: Mental status changes, dementia,

headaches, seizures, lethargy

• Treatment: Biopsy for diagnosis, ± radiation and

chemotherapy

• Peak incidence between 40-50 years, occurs at all ages

• Relentless progression

• Survival ranges from weeks to years

○ Median survival ~ 14 months

(Left) Axial graphic shows

infiltrating tumor involving

frontal lobes, insulae, basal

ganglia with preservation of

the underlying cerebral

architecture. Note the focal

malignant degeneration ﬈.

(Right) Axial T2 MR shows

abnormal hyperintensity in the

left cerebral peduncle ſt and

left temporal and left frontal

lobes with blurring of the

corticomedullary junctions ﬇.

There is subtle expansion of

the involved structures with

relative preservation of the

underlying architecture,

typical of gliomatosis cerebri

(GC).

(Left) Axial FLAIR MR in a 73-

year-old man shows diffuse

hyperintensity throughout the

supratentorial white matter

﬇, thickening the corpus

callosum ſt but preserving

the underlying anatomy. GC

may mimic a nonneoplastic

white matter disease including

arteriolosclerosis. (Right) Axial

T1 C+ MR in the same patient

shows no enhancement,

typical of GC. Enhancement

often correlates with focal

anaplasia or disease

progression. Mild sulcal

effacement is present ﬈.

These infiltrative tumors may

be WHO grade II through IV.

Cysts, and Disorders

Brain: Pathology-Based Diagnoses: Neoplasms,

133

Comments

Search This Blog

Archive

Show more

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

علاقة البيبي بالفراولة بالالفا فيتو بروتين

التغيرات الخمس التي تحدث للجسم عند المشي

إحصائيات سنة 2020 | تعداد سكَان دول إفريقيا تنازليا :

ما هو الليمونير للأسنان ؟

ACUPAN 20 MG, Solution injectable

CELEPHI 200 MG, Gélule

الام الظهر

VOXCIB 200 MG, Gélule

ميبستان

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

Kana Brax Laberax

TRIPASS XR تري باس

PARANTAL 100 MG, Suppositoire بارانتال 100 مجم تحاميل

الكبد الدهني Fatty Liver

الم اسفل الظهر (الحاد) الذي يظهر بشكل مفاجئ bal-agrisi

SEDALGIC 37.5 MG / 325 MG, Comprimé pelliculé [P] سيدالجيك 37.5 مجم / 325 مجم ، قرص مغلف [P]

نمـو الدمـاغ والتطـور العقـلي لـدى الطفـل

CELEPHI 200 MG, Gélule

أخطر أنواع المخدرات فى العالم و الشرق الاوسط

Archive

Show more